Aviva PLC Has $15.47 Million Holdings in Waters Corporation $WAT

Aviva PLC lessened its position in Waters Corporation (NYSE:WAT) by 62.2% in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 44,321 shares of the medical instruments supplier’s stock after selling 73,052 shares during the quarter. Aviva PLC’s holdings in Waters were worth $15,470,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. UMB Bank n.a. lifted its position in shares of Waters by 2.8% in the second quarter. UMB Bank n.a. now owns 1,055 shares of the medical instruments supplier’s stock worth $368,000 after purchasing an additional 29 shares in the last quarter. Integrated Wealth Concepts LLC lifted its position in shares of Waters by 2.9% in the first quarter. Integrated Wealth Concepts LLC now owns 1,048 shares of the medical instruments supplier’s stock worth $386,000 after buying an additional 30 shares during the last quarter. FourThought Financial Partners LLC lifted its holdings in Waters by 5.1% in the 1st quarter. FourThought Financial Partners LLC now owns 658 shares of the medical instruments supplier’s stock worth $243,000 after purchasing an additional 32 shares during the last quarter. Penserra Capital Management LLC lifted its stake in shares of Waters by 13.1% in the second quarter. Penserra Capital Management LLC now owns 327 shares of the medical instruments supplier’s stock worth $114,000 after buying an additional 38 shares during the last quarter. Finally, Horizon Investments LLC boosted its holdings in Waters by 5.2% during the first quarter. Horizon Investments LLC now owns 852 shares of the medical instruments supplier’s stock valued at $314,000 after acquiring an additional 42 shares during the period. 94.01% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on WAT shares. JPMorgan Chase & Co. increased their price objective on Waters from $300.00 to $325.00 and gave the company a “neutral” rating in a research report on Thursday, October 9th. Jefferies Financial Group set a $385.00 price target on Waters and gave the company a “buy” rating in a report on Monday, August 4th. Weiss Ratings reissued a “hold (c)” rating on shares of Waters in a report on Wednesday, October 8th. Wells Fargo & Company boosted their price objective on Waters from $315.00 to $385.00 and gave the company an “equal weight” rating in a research report on Wednesday, November 5th. Finally, Redburn Partners set a $390.00 target price on Waters in a research report on Wednesday, October 8th. Two research analysts have rated the stock with a Strong Buy rating, six have given a Buy rating and nine have given a Hold rating to the company. According to MarketBeat.com, Waters currently has an average rating of “Moderate Buy” and an average target price of $381.57.

Waters Price Performance

Shares of Waters stock opened at $386.37 on Wednesday. The stock has a market capitalization of $23.00 billion, a price-to-earnings ratio of 34.84, a P/E/G ratio of 3.19 and a beta of 1.11. The firm’s 50-day moving average price is $326.85 and its two-hundred day moving average price is $326.62. The company has a current ratio of 1.75, a quick ratio of 1.22 and a debt-to-equity ratio of 0.55. Waters Corporation has a 1-year low of $275.05 and a 1-year high of $423.56.

Waters (NYSE:WAT) last announced its earnings results on Thursday, May 19th. The medical instruments supplier reported $2.29 EPS for the quarter. The business had revenue of $608.55 million for the quarter. Waters had a return on equity of 38.60% and a net margin of 21.71%. On average, equities analysts predict that Waters Corporation will post 12.86 earnings per share for the current fiscal year.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.